Safety and Efficacy of PG102P for Uremic Pruritus in HD Patients

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

March 30, 2019

Conditions
Uremic Pruritus
Interventions
DRUG

PG102P

Daily dose of 1.5g

DRUG

Placebo

Daily dose of placebo

Trial Locations (1)

07061

Seoul National University Boramae Medical Center, Seoul

All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Ewha Womans University Mokdong Hospital

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Chungnam National University Hospital

OTHER

collaborator

Gachon University Gil Medical Center

OTHER

collaborator

Kyungpook National University Hospital

OTHER

collaborator

DongGuk University

OTHER

lead

Seoul National University Boramae Hospital

OTHER

NCT03576235 - Safety and Efficacy of PG102P for Uremic Pruritus in HD Patients | Biotech Hunter | Biotech Hunter